MiNK Therapeutics Inc.

NASDAQ: INKT · Real-Time Price · USD
15.29
-0.03 (-0.20%)
At close: Aug 15, 2025, 3:59 PM
15.02
-1.77%
After-hours: Aug 15, 2025, 05:55 PM EDT

MiNK Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-2.42 -1.64 -3.55 -6.46
PEG Ratio
0.04 0.13 -0.49 -0.14
PS Ratio
n/a n/a 0.03 n/a
PB Ratio
-1.33 -2.04 -219 6.28
P/FCF Ratio
-2.73 -2.32 -4.6 -11.42
P/OCF Ratio
-2.73 -2.33 -4.66 -11.64
OCF/S Ratio
n/a n/a -0.01 n/a
Debt / Equity Ratio
-0.25 n/a n/a n/a
Quick Ratio
0.72 0.32 1.61 2.41
Current Ratio
0.72 0.32 1.61 2.41
Asset Turnover
n/a n/a 125.97 n/a
Interest Coverage
n/a n/a -122.17 -11.66
Return on Equity
0.55 1.24 61.75 -0.97
Return on Assets
-1.89 -4.93 -1.15 -0.57
Return on Invested Capital
-8.58K 3.35 -3.12 -0.91
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a -10.44 n/a
Net Profit Margin
n/a n/a -0.01 n/a
Pretax Profit Margin
n/a n/a -0.01 n/a
Operating Profit Margin
n/a n/a -0.01 n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a -0.01 n/a